429 related articles for article (PubMed ID: 29029862)
1. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
Azzopardi K; Gatt A; Chockalingam N; Formosa C
Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
Bracewell N; Game F; Jeffcoate W; Scammell BE
Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Clinical Methods for Detection of Diabetic Sensory Neuropathy.
Arshad AR; Alvi KY
J Coll Physicians Surg Pak; 2016 May; 26(5):374-9. PubMed ID: 27225141
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
5. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.
Kästenbauer T; Sauseng S; Brath H; Abrahamian H; Irsigler K
Diabet Med; 2004 Jun; 21(6):563-7. PubMed ID: 15154940
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Tests for Peripheral Diabetic Neuropathy in a Type 1 Diabetes Cohort.
César Ernesto LC; Néstor MZ; Raúl IS; Francisco Javier PV; Tania S MU; Francisco BH; Alejandro CM; Marcela JZ; Almeda-Valdes P
Endocr Pract; 2021 Jun; 27(6):567-570. PubMed ID: 33798738
[TBL] [Abstract][Full Text] [Related]
8. Mobile phone generated vibrations used to detect diabetic peripheral neuropathy.
May JD; Morris MWJ
Foot Ankle Surg; 2017 Dec; 23(4):281-284. PubMed ID: 29202988
[TBL] [Abstract][Full Text] [Related]
9. Can the 128-Hz tuning fork be an alternative to the biothesiometer for diabetic peripheral neuropathy screening? A cross-sectional study in a tertiary hospital in East India.
Chattopadhyay S; Goswami S; Sengupta N; Baidya A
BMJ Open; 2024 Jun; 14(6):e082193. PubMed ID: 38862223
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients.
Young MJ; Every N; Boulton AJ
Diabetes Res Clin Pract; 1993 May; 20(2):129-31. PubMed ID: 8375265
[TBL] [Abstract][Full Text] [Related]
11. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
Dimitrakoudis D; Bril V
Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
[TBL] [Abstract][Full Text] [Related]
13. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Glycated Hemoglobin and Vibration Perception Threshold in Diabetic Peripheral Neuropathy.
Maiya AG; Parameshwar A; Hande M; Nandalike V
Int J Low Extrem Wounds; 2020 Jun; 19(2):120-124. PubMed ID: 31838926
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
[TBL] [Abstract][Full Text] [Related]
16. Statin use and peripheral sensory perception: a pilot study.
West B; Williams CM; Jilbert E; James AM; Haines TP
Somatosens Mot Res; 2014 Jun; 31(2):57-61. PubMed ID: 24219409
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
Oyer DS; Saxon D; Shah A
Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
[TBL] [Abstract][Full Text] [Related]
19. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
Jurado J; Ybarra J; Pou JM
Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
Olaleye D; Perkins BA; Bril V
Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
